The study investigates the impact of P-glycoprotein (P-gp) in the intestine on the pharmacokinetics of paclitaxel (Taxol), a cytotoxic drug used in cancer treatment. P-gp, encoded by the *mdr1a* gene, is present in various tissues, including the intestine, and can limit drug absorption and excretion. Using *mdr1a*−/− mice, which lack functional P-gp in the intestine, the researchers found that oral bioavailability of paclitaxel was significantly increased from 11% in wild-type (wt) mice to 35% in *mdr1a*−/− mice. Additionally, fecal excretion of paclitaxel was reduced from 40% in wt mice to below 5% in *mdr1a*−/− mice. The study also observed that direct excretion of paclitaxel into the intestinal lumen was significantly lower in *mdr1a*−/− mice, suggesting that P-gp plays a crucial role in limiting drug absorption and facilitating its excretion. These findings highlight the importance of P-gp in the intestinal absorption and elimination of drugs and provide insights into potential strategies to improve the oral bioavailability of drugs like paclitaxel.The study investigates the impact of P-glycoprotein (P-gp) in the intestine on the pharmacokinetics of paclitaxel (Taxol), a cytotoxic drug used in cancer treatment. P-gp, encoded by the *mdr1a* gene, is present in various tissues, including the intestine, and can limit drug absorption and excretion. Using *mdr1a*−/− mice, which lack functional P-gp in the intestine, the researchers found that oral bioavailability of paclitaxel was significantly increased from 11% in wild-type (wt) mice to 35% in *mdr1a*−/− mice. Additionally, fecal excretion of paclitaxel was reduced from 40% in wt mice to below 5% in *mdr1a*−/− mice. The study also observed that direct excretion of paclitaxel into the intestinal lumen was significantly lower in *mdr1a*−/− mice, suggesting that P-gp plays a crucial role in limiting drug absorption and facilitating its excretion. These findings highlight the importance of P-gp in the intestinal absorption and elimination of drugs and provide insights into potential strategies to improve the oral bioavailability of drugs like paclitaxel.